EP2061498A4 - Compositions and methods to prevent cancer with cupredoxins - Google Patents

Compositions and methods to prevent cancer with cupredoxins

Info

Publication number
EP2061498A4
EP2061498A4 EP07842403A EP07842403A EP2061498A4 EP 2061498 A4 EP2061498 A4 EP 2061498A4 EP 07842403 A EP07842403 A EP 07842403A EP 07842403 A EP07842403 A EP 07842403A EP 2061498 A4 EP2061498 A4 EP 2061498A4
Authority
EP
European Patent Office
Prior art keywords
cupredoxins
compositions
methods
prevent cancer
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07842403A
Other languages
German (de)
French (fr)
Other versions
EP2061498A2 (en
Inventor
Gupta Tapas Das
Ananda Chakrabarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
Original Assignee
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois filed Critical University of Illinois
Publication of EP2061498A2 publication Critical patent/EP2061498A2/en
Publication of EP2061498A4 publication Critical patent/EP2061498A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP07842403A 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins Withdrawn EP2061498A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Publications (2)

Publication Number Publication Date
EP2061498A2 EP2061498A2 (en) 2009-05-27
EP2061498A4 true EP2061498A4 (en) 2009-11-04

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07842403A Withdrawn EP2061498A4 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Country Status (13)

Country Link
EP (1) EP2061498A4 (en)
JP (2) JP2010503409A (en)
KR (1) KR20090059152A (en)
CN (1) CN101595124A (en)
AU (1) AU2007296429A1 (en)
BR (1) BRPI0714987A2 (en)
CA (1) CA2663498A1 (en)
IL (1) IL197602A0 (en)
MX (1) MX2009002787A (en)
NO (1) NO20091267L (en)
RU (1) RU2009113812A (en)
SG (1) SG174784A1 (en)
WO (1) WO2008033987A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
AU2005327535A1 (en) 2004-10-07 2006-08-24 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
WO2007012004A2 (en) 2005-07-19 2007-01-25 The Board Of Trustees Of The University Of Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
BRPI0718360A2 (en) 2006-12-04 2013-11-12 Univ Illinois "COMPOSITIONS AND METHODS FOR CANCER TREATMENT WITH COUPREDOXINS AND RICH DNA IN CPG"
EP2114429A4 (en) * 2007-02-08 2010-05-19 Univ Illinois Compositions and methods to prevent cancer with cupredoxins
CA3075836A1 (en) * 2017-09-29 2019-04-04 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1506375A (en) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition
US20060149037A1 (en) * 2004-10-07 2006-07-06 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof
WO2007018671A2 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2007024368A2 (en) * 2005-07-19 2007-03-01 The Board Of Trustees Of The University Of Illinois Compositions and methods to control angiogenesis with cupredoxins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1506375A (en) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition
US20060149037A1 (en) * 2004-10-07 2006-07-06 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof
WO2007018671A2 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2007024368A2 (en) * 2005-07-19 2007-03-01 The Board Of Trustees Of The University Of Illinois Compositions and methods to control angiogenesis with cupredoxins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PUNJ V ET AL: "Bacterial cupredoxin axurin as an inducer of apoptosis and regression in human breast cancer", ONCOGENE, NATURE PUBLISHING GROUP, GB BASINGSTOKE, HANTS, vol. 23, 1 January 2004 (2004-01-01), pages 2367 - 2378, XP003018759, ISSN: 0950-9232 *

Also Published As

Publication number Publication date
JP2014050390A (en) 2014-03-20
AU2007296429A1 (en) 2008-03-20
CA2663498A1 (en) 2008-03-20
MX2009002787A (en) 2009-08-27
RU2009113812A (en) 2010-10-20
IL197602A0 (en) 2011-08-01
EP2061498A2 (en) 2009-05-27
NO20091267L (en) 2009-06-04
CN101595124A (en) 2009-12-02
SG174784A1 (en) 2011-10-28
WO2008033987A2 (en) 2008-03-20
BRPI0714987A2 (en) 2013-07-30
WO2008033987A3 (en) 2009-04-30
JP2010503409A (en) 2010-02-04
KR20090059152A (en) 2009-06-10

Similar Documents

Publication Publication Date Title
ZA200905508B (en) Compositions and methods to prevent cancer with cupredoxins
IL197602A0 (en) Compositions and methods to prevent cancer with cupredoxins
ZA201001300B (en) Antigen-asjuvant compositions and methods
IL210153A0 (en) Nutrigenomics methods and compositions
EP2035014A4 (en) Fucoidan compositions and methods
EP2086318A4 (en) Neuroprotective compositions and methods
IL212822A0 (en) Anti-cxcr1 compositions and methods
EP2101731A4 (en) Endoxifen methods and compositions
GB0819530D0 (en) Methods and compositions
EP2315600A4 (en) Compositions and methods related to sirt1 function
GB0721291D0 (en) Methods and compositions
EP2370815A4 (en) Anti-inflammatory compositions and methods
EP2088865A4 (en) Guggulphospholipid methods and compositions
GB0617171D0 (en) Novel compositions and methods
GB0719526D0 (en) Compositions and methods
IL213636A0 (en) Compositions and methods to prevent cancer with cupredoxins
GB0713264D0 (en) Improvements in and relating to luminaries
GB0615609D0 (en) Uses and compositions comprising miRNAs
EP2247303A4 (en) Haemostasis- modulating compositions and uses therefor
EP2061493A4 (en) Compositions to reduce or prevent skin cancer
IL213657A0 (en) Compositions and methods to prevent cancer with cupredoxins
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
EP2059122A4 (en) Methods and compositions related to apobec-1 expression
GB0811250D0 (en) Methods and compositions
EP2032146A4 (en) Methods and compositions related to tr4

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090325

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20090430

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/00 20060101AFI20090505BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20091005

17Q First examination report despatched

Effective date: 20100305

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110401